Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: February 20, 2019
Context: The filing announces the Company's fourth quarter and full fiscal year 2018 results via a press release furnished as Exhibit 99.1. The report includes both IFRS-compliant figures and non-GAAP financial measures.
Key Financial Metrics
The provided text serves as a cover sheet and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being located in the attached Press Release (Exhibit 99.1) and financial figures (Exhibit 99.2).
Non-GAAP Measures Disclosed: The filing explicitly states the use of the following non-GAAP measures to supplement IFRS results:
- EBITDA (Operating income excluding interest, taxes, depreciation, and amortization)
- Delivered operating income (Earnings before interest and taxes)
- Free cash flow
- Results presented in constant currency
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It notes that non-GAAP measures are used to provide consistency and comparability to prior periods, but specific variance percentages or amounts are not included in this document.
Guidance, Outlook, and Risks
Management Commentary: Management states that non-GAAP measures are provided to enhance the user's understanding of current financial performance and future prospects. They emphasize that these measures should not be used as a substitute for GAAP/IFRS financial measures.
Risks and Contingencies: The text includes standard legal disclaimers stating that the attached exhibits are not deemed "filed" for purposes of Section 18 of the Exchange Act and are not subject to the liabilities of that section. No specific operational risks or contingencies are detailed in this cover text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 and FY2018 revenue, EBITDA, and net income figures.
- Examine Exhibit 99.2 for the detailed reconciliation of non-GAAP measures to IFRS financial measures.
- Verify the "constant currency" adjustments to understand the impact of foreign exchange rates on reported growth.
- Check the Cash Flow Statement referenced in the text for the specific calculation of free cash flow.